Abstract
Necrotizing enterocolitis remains a serious condition in very low birth weight infants, particularly in those infants who require surgery. Perioperative hemorrhage is a potentially fatal complication in this population. We describe our experience in 4 premature infants with necrotizing enterocolitis who received recombinant factor VIIa to manage life-threatening intraoperative hemorrhage.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Enterocolitis, Necrotizing / surgery*
-
Factor VIIa / therapeutic use*
-
Hemorrhage / drug therapy*
-
Humans
-
Infant
-
Infant, Newborn
-
Infant, Premature*
-
Infant, Very Low Birth Weight*
-
Intraoperative Complications / drug therapy*
-
Laparotomy
-
Liver Diseases / drug therapy*
-
Recombinant Proteins / therapeutic use*
-
Rupture, Spontaneous
-
Treatment Outcome
Substances
-
Recombinant Proteins
-
Factor VIIa